Remove stagnant-sales-dermavants-vtama-cast-doubt-its-blockbuster-potential
article thumbnail

Stagnant sales for Dermavant's Vtama cast doubt on its blockbuster potential

Fierce Pharma

In the market, however, Vtama is struggling to catch on. As a result, Leerink Partners has slashed its sales projections for the nonsteroidal topical treatment.

Sales 192